Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × Radiopharmaceuticals × Genitourinary × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Clear-cell metastatic renal cell carcinoma 1

Interventions

Specimen Handling 5 Nivolumab 3 Magnetic Resonance Spectroscopy 3 gallium 68 PSMA-11 2 Ipilimumab 2 Docetaxel 2 Carboplatin 2 Biopsy 2 tivozanib 1 talazoparib 1 romidepsin 1 pembrolizumab 1 imisopasem manganese 1 durvalumab 1 cabazitaxel 1 balstilimab 1 atezolizumab 1 abivertinib 1 abiraterone 1 abarelix 1 Watchful Waiting 1 Testosterone Propionate 1 Testosterone 1 Radiosurgery 1 Radiopharmaceuticals 1 Physical Therapy Modalities 1 Palliative Care 1 Paclitaxel 1 Oxycodone 1 Observation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06059014 2025-02-24

PRadR

Centre Leon Berard

Phase 1/2 Suspended

Clear-cell metastatic renal cell carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡